SANA
Sana Biotechnology, Inc. · Healthcare
Director Richard Mulligan sold $1.2M of Sana Biotechnology, Inc.
Sold$1,195,740
$3.99Price
300,000Shares
−10%Stake
What SANA did after the filing
- The stock from Fri, Sep 27 open, $4.21
- −28.6%
- S&P 500, same days
- +4.3%
Measured over 30 trading days, to the Nov 8 close.
Traded Tue, Sep 24. Filed Thu, Sep 26, 4:07 PM ET, after the close. Returns use the Sep 27 open and the Nov 8 close. Not investment advice.